Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma

As therapy for locally advanced non-small-cell lung carcinoma (NSCLC) improves, brain metastases (BM) may become a greater problem. We analyzed our chemoradiation experience for patients at highest risk for the brain as the first failure site. Records for 150 consecutive patients with stage II/III N...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2001-03, Vol.19 (5), p.1344-1349
Hauptverfasser:	ROBNETT, Theodore J, MACHTAY, Mitchell, STEVENSON, James P, ALGAZY, Kenneth M, HAHN, Stephen M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Biological and medical sciences Brain Neoplasms - etiology Brain Neoplasms - radiotherapy Brain Neoplasms - secondary Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - radiotherapy Carcinoma, Non-Small-Cell Lung - secondary Combined Modality Therapy Combined treatments (chemotherapy of immunotherapy associated with an other treatment) Cranial Irradiation Female Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Male Medical sciences Middle Aged Pharmacology. Drug treatments Prognosis Retrospective Studies Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!